Health
Ludwig Chicago study identifies a novel drug target for the control of cancer metastasis – EurekAlert
Researchers led by Ludwig Chicago Co-director Ralph Weichselbaum and Ronald Rock of the University of Chicago have identified in preclinical studies a potential drug target for curtailing cancer metastasis.
AUGUST 24, 2020, NEW YORK – Researchers led by Ludwig Chicago Co-director Ralph Weichselbaum and Ronald Rock of the University of Chicago have identified in preclinical studies a potential drug target for curtailing cancer metastasis.
Their study, published in the Proceedings of the National Academy of Sciences, describes how a compound named 4-hydroxyacetophenone (4-HAP) activates a specific protein motor in cells and so monkey-wrenches biomechanical processes essential to cell motility. It a…
-
Noosa News24 hours agoWoman charged with Mark Akers’s murder after body found on roadside
-
General21 hours agoMaría Corina Machado awarded Nobel Peace Prize
-
General20 hours agoDonald Trump didn’t receive the Nobel Peace Prize. Experts say he had ‘no chance’ at winning
-
Business9 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies